 By Nina Julia. SFAH.org
It’s challenging to find a place that wouldn’t stock CBD today, at least in its traditional oil form. CBD oil has taken the United States by storm, driving the attention of doctors, researchers, and media outlets across the world. Universities are starting their research on the possibility of treating a variety of health conditions with CBD, including cancer. As CBD continues to change the public perception of cannabis, more people than ever are turning to CBD oil as a natural alternative for their ailments. In this article, we’re going to shed light on scientific research concerning the potential use of CBD oil for cancer and its symptoms. We’ll also provide our list of recommended CBD oils that could potentially help individuals on their way to safe recovery. What is CBD? CBD is one of over 100 compounds in cannabis plants, which are categorized as cannabinoids. Unlike its psychoactive cousin THC, CBD can’t make you feel high. However, it still offers a plethora of benefits for our health. It turns out that all mammals have an endocannabinoid system (discovered in the 1990s), which is a prime self-regulatory network composed of cannabinoid receptors and neurotransmitters known as endocannabinoids. Endocannabinoids are chemical messengers that are released to maintain homeostasis in the body, which is a state of equilibrium between all bodily functions, such as pain signaling, appetite, sleep cycles, immune function, emotional processing, and more. CBD acts as a modulator, meaning it signals the endocannabinoid system to produce and maintain more of its native cannabinoids to help them effectively maintain the balance within the body. CBD can also help the endocannabinoid system regain its proper functioning when homeostasis has been disrupted. Through the said signaling, it can promote the formation of healthy cells in the body while turning on the process of apoptosis — the destruction of malignant cells. People use CBD for a wide range of health problems, from common anxiety to inflammatory conditions and severe chronic diseases, such as arthritis, epilepsy, autism, and cancer. Read more...
1 Comment
 In this March 24, 2017, photo, bottles of hemp oil, or CBD, are for sale at the store Into The Mystic in Mission, Kansas. (Allison Long/The Kansas City Star via AP) By Patricia Kime, Military.com
U.S. troops can now be punished for using products that contain hemp or cannabidiol, according to a Defense Department memo recently made public. In February, Acting Under Secretary of Defense for Personnel and Readiness Matthew Donovan directed the services to issue general orders or regulations by March 1 prohibiting the use of products made from hemp under Article 92 of the Uniform Code of Military Justice. Donovan's memo, dated Feb. 26, was highlighted Monday in a tweet by the DoD's Operation Supplement Safety, an initiative within the Uniformed Services University of the Health Sciences that provides information to service members on dietary supplements. Troops have known since last year that most products containing cannabidiol, or CBD, were off-limits, with two of the four DoD services issuing guidance restricting use of any form of CBD, including in supplements, creams, ointments and tinctures. But the new orders make use of hemp and CBD punitive across all DoD active-duty and reserve component personnel, including the Navy and Marine Corps, whose members were allowed under the Department of the Navy to use topical products like shampoo, lotions and creams. Donovan said the move was needed to "protect the integrity of the drug testing program." "I specifically find a military necessity to require a prohibition of this scope to ensure the military drug testing program continues to be able to identify the use of marijuana, which is prohibited, and to spare the U.S. military the risks and adverse effects marijuana use has on the mission readiness of individual service members and military units," he wrote. The federal government removed hemp from its list of controlled substances under the Agriculture Improvement Act of 2018. By law, hemp that contains less than .3% THC (delta-9-tetrahydrocannabinol, the psychoactive ingredient in marijuana) is legal. Read more...  By Ivan Moreno, HempIndustryDaily.com Testing of CBD-infused products conducted by the U.S. Food and Drug Administration found that many are mislabeled, containing far less or more CBD than advertised and in some instances THC that wasn’t supposed to be there. Of the 102 products tested this year that were labeled as having CBD, 18 had less than 80% of the amount indicated, while another 46 were within 20% of the amount advertised. Thirty-eight products had more than 120% of the CBD indicated. The results were included in an undated letter to Congress that Hemp Industry Daily obtained Wednesday. An FDA spokesman confirmed the letter but declined to comment on the findings. In all, the FDA tested 147 products. Not all were labeled as having CBD, but 138 contained at least some amount of the cannabinoid. Of the 147 products, 72 contained some THC, although the concentrations were low. The testing included:
The products were chosen at random after the FDA searched the internet for products. The agency also chose products from:
The federal agency repeatedly noted that the testing was from a limited sample size and that no definitive conclusions could be drawn, but “supports the need for” long-term study. The FDA said in its letter that it “recognizes the significant public interest in CBD products.” “However, there are many questions about the characteristics of currently marketed CBD products.” Read more...  Raphael Mechoulam, also known as the “father of cannabis research,” By Javier Hasse, Senior Contributor, Forbes Magazine
Professor Raphael Mechoulam, also known as the “father of cannabis research,” revealed his latest discovery, cannabidiolic acid methyl ester (EPM301), only a few months ago. The introduction of this new, patented compound (synthetic, fully stable acid-based cannabinoid molecules) caused a wave of excitement around the future of medicinal cannabis. The compound in question was presented to the world in partnership with EPM, a global biotechnology company based in the U.S. that aims to bridge the gap between the cannabis and pharmaceutical industries. During a recent, exclusive conversation, CEO Reshef Swisa and Dr. Mechoulam, shared the history of the journey behind this revolutionary process and its significance in evolving the use of CBD as a pharmaceutical drug. Meet EPM301 “EPM developed a method to work with the original substances of cannabis,” the Professor explained. “So, while everybody is discussing THC and CBD, these cannabinoids are actually a secondary substance; they only appear later in the plant. “Originally there is an acid that appears in the plant, and those acids are these mysterious worlds of compounds that are much more potent than cannabinoids,” he added. See also: University Of Toronto, Canadian Biotech Company Collaborate On Cannabinoid-Based COVID-19 Treatment However, these cannabidiolic acids were unstable, and therefore useless in pharmaceutical drug development. Until now, that is. Mechoulam’s recent revelation stems from the development of a method that allows to modify the acids in a way that keeps them stable enough to allow for their larg- scale use. This opens the door for further pharmaceutical experiments, the professor explained. Read more...  Survey: 84% of CBD Consumers Believe that CBD can Replace Opiods. By Graham Abbott By Graham Abbott, ganjapreneur.com
A recent survey of more than 1,450 CBD consumers revealed that most use CBD to treat chronic pain, and 84% believe CBD is an effective replacement for opioids. About 84% of CBD consumers believe the cannabinoid is an effective alternative to opioids, according to a recent study from AmericanMarijuana.org. The study surveyed 1,453 consumers who reported using CBD as a pain relief treatment. While the majority of respondents were both regular CBD consumers and millennials, non-regular users represented about one-third of respondents, while Baby Boomers represented about 8% of respondents, Gen Z represented about 12%, and Gen X about 19%. A whopping 97% of respondents reported using fewer opioids after starting CBD — about 57% said they were using fewer opioids while some 40% said they had stopped their opioid use altogether. 53% of respondents said that CBD had become their only source of pain relief. Read more...  By Sarah Young @sarah_j_young, Independant.co
The 89-year-old actor said that he has been taking cannabis extracts such as CBD (cannabidiol) and THC (tetrahydrocannabinol) to help manage pain and swelling in his joints. Speaking to the PA news agency, the Star Trek star said: “I've got some aches and pains I didn't have a few years ago. But, I'm finding out there are many things that help aches and pains that we didn't know about just a few years ago.” He continued: “Well, THC and CBD, and that kind of thing. It's magical. I've had swollen joints where it hurts, you rub some on and while you're rubbing it on, the pain disappears. It's magical." Read more...  By Mary Biles, ProjectCBD.org
In the recent annals of medical cannabis history, a defining moment came in 2013 when CNN Health Correspondent Sanjay Gupta reported on how the seemingly miraculous antiseizure effects of cannabidiol (CBD) transformed the life of a five-year-old Colorado resident, Charlotte Figi. Where 17 other anti-epilepsy medications had failed to control Charlotte’s grand mal seizures, a CBD-rich cannabis oil extract brought them down to almost zero. Suddenly, arguing that cannabis had no therapeutic benefit became untenable and medical cannabis acquired a new legitimacy – even if the U.S. government is still playing catch-up seven years later. As fate would have it, Charlotte and her devoted parents were lucky to get some prescient advice from an unsung hero. Without the willingness of a self-confessed “conservative” physician to recommend high CBD/low THC cannabis for Charlotte, we might still be living in a far more hostile medical cannabis environment. That physician is Alan Shackelford, MD. Read more...  How CBD Works To improve Your Health, by Ali Luffman By Ali Luffman, Healthtechzone.com
Marijuana is everywhere nowadays. You can see it in the news, on social media, in magazines, and on the internet. It has made many people curious about the potential uses of the plant. However, you may not be aware that someone is talking about cannabis as they may use the term ‘CBD’. Many people have never heard of CBD, and they get confused when weed is associated with it. If you don't understand what CBD is, how it works, and its potential health benefits, then here is everything you need to know. What Is Cannabidiol (CBD)? It is a cannabinoid that is produced in the hemp plant. There are many strains of the plant, but the Sativa strain is mostly used to make CBD. It is extracted from the cannabis buds and flowers. People often think that all forms of marijuana make people ‘high’ but in reality it’s the THC that gives the high feeling. CBD is a non-psychoactive drug, which means it doesn't give a euphoric feeling when consumed. Marijuana gets its flavor and taste from compounds called terpenes. But don’t think they are artificially added, they are naturally found in the plant. These compounds can either be psychoactive or non-psychoactive. Read more...  Peter Grinspoon, MD By Peter Grinspoon, MD, Harvard Health Cannabidiol (CBD) has been recently covered in the media, and you may have even seen it as an add-in booster to your post-workout smoothie or morning coffee. What exactly is CBD? Why is it suddenly so popular? How is cannabidiol different from marijuana?CBD stands for cannabidiol. It is the second most prevalent of the active ingredients of cannabis (marijuana). While CBD is an essential component of medical marijuana, it is derived directly from the hemp plant, which is a cousin of the marijuana plant. While CBD is a component of marijuana (one of hundreds), by itself it does not cause a “high.” According to a report from the World Health Organization, “In humans, CBD exhibits no effects indicative of any abuse or dependence potential…. To date, there is no evidence of public health related problems associated with the use of pure CBD.” Is cannabidiol legal?CBD is readily obtainable in most parts of the United States, though its exact legal status is in flux. All 50 states have laws legalizing CBD with varying degrees of restriction, and while the federal government still considers CBD in the same class as marijuana, it doesn’t habitually enforce against it. In December 2015, the FDA eased the regulatory requirements to allow researchers to conduct CBD trials. Currently, many people obtain CBD online without a medical cannabis license. The government’s position on CBD is confusing, and depends in part on whether the CBD comes from hemp or marijuana. The legality of CBD is expected to change, as there is currently bipartisan consensus in Congress to make the hemp crop legal which would, for all intents and purposes, make CBD difficult to prohibit. The evidence for cannabidiol health benefitsCBD has been touted for a wide variety of health issues, but the strongest scientific evidence is for its effectiveness in treating some of the cruelest childhood epilepsy syndromes, such as Dravet syndrome and Lennox-Gastaut syndrome (LGS), which typically don’t respond to antiseizure medications. In numerous studies, CBD was able to reduce the number of seizures, and in some cases it was able to stop them altogether. Videos of the effects of CBD on these children and their seizures are readily available on the Internet for viewing, and they are quite striking. Recently the FDA approved the first ever cannabis-derived medicine for these conditions, Epidiolex, which contains CBD. Read more...  Cannabidiol (CBD) — what we know and what we don’t, by Peter Grinspoon, MD  Photo by Robert Nelson | https://tricy.cl/2FMFNtU By Matthew Abrahams, Tricycle Magazine
The cannabis product has been popping up in many yoga and meditation classes. But is the trending stress reliever worth all the hype? At a trendy meditation studio in Manhattan, a seemingly distracted desk attendant pointed me to three vials of CBD oil and a jar of tiny spoons. I took one eyedropper full and headed to a colorful room to lie down and listen to a guided meditation that told me to imagine myself floating above the Earth, looking down from my spaceship. And I thought, why do I need a spaceship to imagine myself in space? I soon realized this was not a good fit for me. The plan had been to look into the growing trend of CBD oil use in meditation. Online testimonials said that the stress-relieving qualities of CBD and meditation could work in concert to melt away the anxieties of the modern world. But I wasn’t seeing it. Cannabidiol, or CBD, is one of more than 60 cannabinoid compounds found in a marijuana plant, which includes the substance most commonly associated with the “stoned” effect, THC (tetrahydrocannabinol). CBD is legal, to varying degrees, in 46 states. New York legalized it in 2014, in part due to the efforts of Gov. Andrew Cuomo, who argued at the time that it would be a mistake to outlaw the substance that had been shown to be one of the few ways of treating cases of medication-resistant childhood epilepsy. (He also viewed the hemp industry as a way to bring new jobs to the economically hard-hit Southern Tier region.) Since then, multiple studies have found that CBD offers many of the benefits long touted by proponents of legal marijuana without the psychotropic effects. In other words, it doesn’t get you high. Even better, researchers have found few side effects associated with CBD use. Among its purported benefits, CBD studies have found promising results for its anti-anxiety and anti-inflammatory qualities. Read more... |
WeLiBo™️WeLiBo™️, based in San Francisco CA, is a premier topical CBD brand. ArchivesCategories
All
|
RSS Feed
